TERT and cutaneous melanoma: Using new sequence-based approaches to comprehensively scan the genome for non-coding mutations with potential functional impact, mutations in the telomerase reverse transcriptase (TERT) promoter, which encodes the catalytic subunit of telomerase, were identified at high frequencies in cutaneous melanoma (141).